๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin

โœ Scribed by Mats Mellander; Bruno Leheup; Daniel P. Lindstrom; Charlotte Palme; Thomas P. Graham Jr.; Mildred T. Stahlman; Robert B. Cotton

Book ID
119460760
Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
455 KB
Volume
105
Category
Article
ISSN
1097-6833

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Retrolental fibroplasia in premature inf
Retrolental fibroplasia in premature infants with patent ductus arteriosus treated with indomethacin
โœ R. Lindemann; W. Blystad; K. Egge ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Springer ๐ŸŒ English โš– 280 KB

Sixteen premature infants were treated with indomethacin, either orally or intravenously, in order to close a symptomatic patent ductus arteriosus requiring mechanical ventilation. Positive effect was obtained in 4 of the 10 orally treated patients and in 1 of the 6 with intravenous administration.

Indomethacin and cerebral blood flow in
Indomethacin and cerebral blood flow in premature infants treated for patent ductus arteriosus
โœ O. Pryds; G. Greisen; K. H. Johansen ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 172 KB

Central blood flow (CBF) was estimated by an intravenous 133-xenon technique in six preterm infants before and after administration of indomethacin for closure of patent ductus arteriosus. CBF fell in all infants (range 12%-40%), the mean fall was 24% (P less than 0.005). Though none of the infants